Long-Term Real-World Evaluation of Abrocitinib in Moderate-to-Severe Atopic Dermatitis Across a Diverse Patient Population in a Multi-site Hospital System
Fields of Study & Subjects
Dermatology and Skin Diseases
Psoriasis: Treatment and Pathogenesis
Drug-Induced Adverse Reactions
Publication details
- Journal / source
- American Journal of Clinical Dermatology
- Publisher
- Springer Science and Business Media LLC
- Volume
- 27
- Issue
- 2
- Pages
- 401–410
- Publication date
- 27 January 2026
- Language
- EN